SCHOTT Home

Press & Events: Always Up-To-Date, Always Informed.

Our latest press releases, publications, trade show schedule and our customer magazine – find all of it right here.

10.12.2009, SCHOTT AG
New Innovative Staked Needle Syringe
SCHOTT InJentle™ - Drug Friendly, Patient Friendly
Improved drug stability / no leachables from adhesives / gentle application

Mainz, December 8, 2009 – SCHOTT has developed a new and highly innovative syringe system. The new product was presented under the brand SCHOTT InJentle™ at the SCHOTT Pharma Symposium in Mainz, Germany, in December 2009. SCHOTT InJentle™ was developed for the special needs of highly sensitive drugs. Its unique design offers improved drug stability and a gentle application. “The drug is not in contact with the needle or the adhesive during storage”, says Carmen Heiter, Product Manager Syringes. “This prevents sensitive drugs from interacting with the adhesive or the metal of the needle.” The innovative seal design allows the drug only to flow into the needle at the very moment when the syringe is opened, i.e. when the needle shield is pulled off. The tamper-evident closure enables physicians or patients to determine if the syringe is still unused.

SCHOTT Pharmaceutical Packaging has developed a new staked needle syringe. The innovative seal design of InJentle(TM) syringes allows the drug only to flow into the needle at the very moment when the syringe is opened, i.e. when the needle shield is pulled off. The drug is not in contact with the needle or the adhesive during storage and prevents sensitive drugs from interacting with the adhesive or the metal of the needle.
Mainz, December 8, 2009 – SCHOTT has developed a new and highly innovative syringe system. The new product was presented under the brand SCHOTT InJentle™ at the SCHOTT Pharma Symposium in Mainz, Germany, in December 2009. SCHOTT InJentle™ was developed for the special needs of highly sensitive drugs. Its unique design offers improved drug stability and a gentle application.

“The drug is not in contact with the needle or the adhesive during storage”, says Carmen Heiter, Product Manager Syringes. “This prevents sensitive drugs from interacting with the adhesive or the metal of the needle.” The innovative seal design allows the drug only to flow into the needle at the very moment when the syringe is opened, i.e. when the needle shield is pulled off. The tamper-evident closure enables physicians or patients to determine if the syringe is still unused.

SCHOTT InJentle™ exhibits a whole range of additional advantages. For example, the special geometry of the glass barrel does not require the use of any tungsten during the glass forming process. As a result, the syringe is completely tungsten-free.

“There is a growing segment of biotech drugs that are not only highly effective but also very sensitive,” explains Ralf Bouffleur, Vice President SCHOTT Pharmaceutical Packaging. “The reliable protection of these drugs during storage is now calling for innovative packaging solutions like SCHOTT InJentle™.”

SCHOTT InJentle™ allows the use of particularly thin needles up to 32 gauge. “The thinner the needle,” according to Heiter, “the less painful the injection.” As SCHOTT InJentle is very simple to handle, no special training is required for the healthcare personnel. “But although this syringe includes a number of special features, the syringe is delivered with standard nests and tubs”, says Heiter, “and can be filled on standard filling lines”.

A production line is currently being built to manufacture the InJentle syringe, with mass production planned to start at the end of 2010 in St. Gallen, Switzerland. Samples in 1ml long format are available for functionality testing. “SCHOTT InJentle is both “drug friendly” and “patient friendly””, says Carmen Heiter. “On the one hand, it enables even very sensitive drugs to be stored safely, on the other hand it offers easy handling and the ability to use particularly thin needles for a gentle application.”
SCHOTT AG
 
20091210150254_InJentle_EN.pdf
Further information:
SCHOTT AG
Matthias Reinig
E-mail
 
SCHOTT forma vitrum ag
Christa Fritschi
E-mail
http://www.schott.com/pharmaceutical_systems
back
 
 
Press

Press Releases

Every SCHOTT press release archived chronologically. More
Publications

Publications

Company portrait, customer magazine, annual report and information on our history, all available for download. More
Solutions magazine

Customer Magazine "SCHOTT solutions"

In both German and English, the magazine lands on your table or appears on your monitor: Articles, reports and interviews on ideas and solutions from SCHOTT to the technological challenges worldwide. More
Trade Fairs

Trade Shows & Events

SCHOTT exhibits its products at the most important trade shows around the world. All trade show and event dates at a glance. More
Image Database

Image Database

Images from the SCHOTT press archive for viewing and downloading. More
Media Contacts

Media Contacts

Find your contacts from our Public Relations department. More
Contact

SCHOTT AG

Hattenbergstrasse 10
55122 Mainz
Germany
 +49 (0)6131/66-0
 +49 (0)6131/66-2000
E-mail
Directions
More contacts
Trade Fairs & Events

06.09 - 09.09.2010

25. European Photovoltaic Solar Energy Conference and Exhibition

Valencia

06.09 - 09.09.2010

CIOE

Shenzen

12.09 - 15.09.2010

European SAP 2010

Paris

21.09 - 24.09.2010

SolarPACES 2010

Perignan

More trade fairs